Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · IEX Real-Time Price · USD
35.95
-0.05 (-0.14%)
At close: Jul 19, 2024, 4:00 PM
35.88
-0.07 (-0.19%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for LBPH stock have an average target of 45.38, with a low estimate of 16 and a high estimate of 80. The average target predicts an increase of 26.23% from the current stock price of 35.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LBPH stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 3 | 4 | 4 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $36 → $60 | Buy | Maintains | $36 → $60 | +66.90% | Jul 11, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +25.17% | Jul 2, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $57 → $80 | Buy | Maintains | $57 → $80 | +122.53% | Jul 2, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $44 → $57 | Buy | Maintains | $44 → $57 | +58.55% | Jun 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $60 | Buy | Reiterates | $60 | +66.90% | Jun 20, 2024 |
Financial Forecast
Revenue This Year
3.83M
Revenue Next Year
n/a
from 3.83M
EPS This Year
-1.88
from -2.39
EPS Next Year
-2.33
from -1.88
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.8M | n/a | 21.7M | 98.6M | 344.6M |
| Avg | 3.8M | n/a | 6.9M | 56.2M | 224.3M |
| Low | n/a | n/a | n/a | n/a | 13.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,328.1% | 513.7% |
| Avg | - | - | - | 713.4% | 299.4% |
| Low | - | - | - | - | -75.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.71 | -1.80 | -2.09 | -2.98 | -1.20 |
| Avg | -1.88 | -2.33 | -2.66 | -3.47 | -2.02 |
| Low | -2.06 | -2.69 | -3.30 | -4.21 | -3.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.